Atrial Fibrillation in Robotic Assisted Mitral Valve Repair


About this study

The purpose of this study is:

  1. To assess whether corrective rhythm procedure during robotic mitral valve repair produce reliable long-term results.
  2. To determine the incidence of new onset atrial fibrillation after robotic mitral valve repair.
  3. To determine whether rhythm plays a role in long term valvular function.
  4. As a secondary aim, we would like to study the outcomes of small subset of patients (10 patients) who underwent robotically assisted left atrial mass removal.
  5. As a secondary aim, we also plan to look at our robotic patients and compare them to the conventional repair cohort to study the various echocardiographic parameters.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All patients undergoing Robotic mitral valve repair from 2008-16.
    • A similar number of patients undergoing conventional mitral valve repair.

Exclusion Criteria: 

  • Non-consenting patients 
  • Patients undergoing other concomitant surgery

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Simon Maltais, M.D., Ph.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer